Search Results
Breadcrumb Home Search ClinicalTrials.gov ID: For more information on this trial, visit clinicaltrials.gov . Summary Eligibility Contact Summary Eligibility Criteria Min Age N/A Max Age N/A Download Date Principal Investigator N/A Primary Contact …
Breadcrumb Home Search ClinicalTrials.gov ID: For more information on this trial, visit clinicaltrials.gov . Summary Eligibility Contact Summary Eligibility Criteria Min Age N/A Max Age N/A Download Date Principal Investigator N/A Primary Contact …
Breadcrumb Home Search ClinicalTrials.gov ID: For more information on this trial, visit clinicaltrials.gov . Summary Eligibility Contact Summary Eligibility Criteria Min Age N/A Max Age N/A Download Date Principal Investigator N/A Primary Contact …
Breadcrumb Home Search ClinicalTrials.gov ID: For more information on this trial, visit clinicaltrials.gov . Summary Eligibility Contact Summary Eligibility Criteria Min Age N/A Max Age N/A Download Date Principal Investigator N/A Primary Contact …
Breadcrumb Home Search ClinicalTrials.gov ID: For more information on this trial, visit clinicaltrials.gov . Summary Eligibility Contact Summary Eligibility Criteria Min Age N/A Max Age N/A Download Date Principal Investigator N/A Primary Contact …
Breadcrumb Home Search ClinicalTrials.gov ID: For more information on this trial, visit clinicaltrials.gov . Summary Eligibility Contact Summary Eligibility Criteria Min Age N/A Max Age N/A Download Date Principal Investigator N/A Primary Contact …
Breadcrumb Home Search ClinicalTrials.gov ID: For more information on this trial, visit clinicaltrials.gov . Summary Eligibility Contact Summary Eligibility Criteria Min Age N/A Max Age N/A Download Date Principal Investigator N/A Primary Contact …
NCT02931682 NCT02931682 Observational Study of Males With Creatine Transporter DeficiencyThe objectives of this study are to illustrate the clinical, neuro/electrophysiologic, biochemical, and developmental status and progression of patients …
NCT02932410 NCT02932410 A Study to Assess Whether Macitentan Delays Disease Progression in Children With Pulmonary Arterial Hypertension (PAH)This is a prospective, multicenter, open-label, randomized, controlled, parallel Phase 3 study with an …
Breadcrumb Home Search ClinicalTrials.gov ID: For more information on this trial, visit clinicaltrials.gov . Summary Eligibility Contact Summary Eligibility Criteria Min Age N/A Max Age N/A Download Date Principal Investigator N/A Primary Contact …